Medium materiality6/10
Quest Diagnostics price target raised to $260 from $250 at Truist
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Truist raises Quest Diagnostics target to $260; price $246.48.
- DGX target to $260; price $246.48.
Key facts
- 01
Target: $260
- 02
Posted price: $246.48
- 03
Analyst firm: Truist Financial
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.